V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10308006 | 10039137 | 1.72 | 51.6 | Curative (C) | 2017-08-05 | 2017-08-31 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100956164 |
| 10308023 | 10039138 | null | 0 | null | 2022-01-18 | 2022-02-12 | CISPLATIN + FLUOROURACIL | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100988304 |
| 10308032 | 10039139 | 1.65 | 65 | 03 | 2018-05-30 | 2018-06-21 | BORTEZOMIB + THALIDOMIDE | 02 | N | BORTEZOMIB + THALIDOMIDE | 101418135 |
| 10308041 | 10039140 | 1.57 | 54.2 | Palliative (P) | 2017-05-19 | 2017-05-19 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101721010 |
| 10308051 | 10039141 | 1.64 | 74 | null | 2018-02-17 | 2018-02-17 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100908064 |
| 10308055 | 10039142 | 1.65 | 85.8 | null | 2018-09-07 | 2018-09-07 | IPILIMUMAB + NIVOLUMAB | 02 | Y | IPILIMUMAB + NIVOLUMAB | 100021878 |
| 10308278 | 10039143 | 1.61 | 83.6 | Disease modification (D) | 2019-03-26 | 2019-05-22 | POMALIDOMIDE | N | N | SUNITINIB | 100545725 |
| 10308285 | 10039144 | 1.66 | 0.1 | 03 | 2019-07-23 | 2019-08-13 | MITOMYCIN | 02 | N | CISPLATIN + VINORELBINE | 100568706 |
| 10308350 | 10039147 | null | null | Disease modification (D) | 2017-03-09 | 2017-04-19 | Folfirinox | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100245264 |
| 10308367 | 10039148 | 1.68 | 77.6 | Curative (C) | 2017-05-28 | 2017-05-30 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100747079 |
| 10308370 | 10039149 | 1.75 | null | Curative (C) | 2017-07-31 | 2017-08-05 | BCG Intravesical | 02 | null | BCG | 100030052 |
| 10308393 | 10039150 | 1.65 | 88 | Curative (C) | 2019-02-09 | 2019-02-11 | Venetoclax | 02 | N | SUNITINIB | 101182015 |
| 10308400 | 10039151 | 1.69 | 100 | Disease modification (D) | null | 2016-06-18 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101050179 |
| 10308476 | 10039152 | 1.53 | 90 | Curative (C) | 2019-05-25 | 2019-05-30 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101102273 |
| 10308480 | 10039153 | 0 | 78.6 | Adjuvant (A) | 2017-05-07 | 2017-05-07 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100648348 |
| 10308524 | 10039155 | 1.65 | 98.4 | Palliative (P) | 2018-12-26 | 2018-12-26 | Gemcitabine + Capecitabine | 02 | N | CISPLATIN + FLUOROURACIL | 101452188 |
| 10308533 | 10039156 | 1.82 | 83.8 | Curative (C) | 2018-04-28 | 2018-04-30 | Gemcitabine + Capecitabine | 02 | N | CISPLATIN + FLUOROURACIL | 100430234 |
| 10308624 | 10039157 | 0 | null | Palliative (P) | 2017-08-08 | 2017-08-08 | Busulfan Oral | N | Y | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101030613 |
| 10308710 | 10039158 | null | null | Palliative (P) | 2018-12-23 | 2019-01-15 | DABRAFENIB + TRAMETINIB | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100550271 |
| 10308763 | 10039160 | 1.56 | 72.1 | Palliative (P) | 2017-10-17 | 2017-10-17 | Busulfan Oral | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101103446 |
| 10308796 | 10039161 | null | null | null | 2018-07-13 | 2018-07-13 | Cisplatin +Fluorouracil (3 wk) | N | Y | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100133888 |
| 10308807 | 10039162 | null | 79.6 | Palliative (P) | null | 2021-08-27 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101846026 |
| 10308808 | 10039163 | 1.67 | 76.9 | Curative (C) | 2017-01-29 | 2017-01-30 | Cyclophosphamide + Docetaxel | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100031900 |
| 10308861 | 10039166 | 1.48 | 57.8 | null | 2019-07-24 | 2019-07-25 | Folfirinox | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100234196 |
| 10308939 | 10039167 | null | 72.8 | Disease modification (D) | 2018-05-08 | 2018-05-22 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100254508 |
| 10308943 | 10039168 | 1.61 | 82.4 | null | 2021-01-03 | 2021-01-20 | Venetoclax | N | null | DABRAFENIB + TRAMETINIB | 100411063 |
| 10308987 | 10039170 | 1.67 | 64.7 | null | 2022-02-22 | 2022-03-05 | CISPLATIN + VINORELBINE + RT | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 101416867 |
| 10309011 | 10039171 | 1.52 | 75.8 | Curative (C) | 2020-08-13 | 2020-08-17 | Busulfan Oral | Y | null | CYTARABINE | 100296989 |
| 10309156 | 10039172 | 1.85 | 86 | Palliative (P) | 2019-05-24 | 2019-05-24 | Cytarabine Low Dose | 02 | N | CAPECITABINE + GEMCITABINE | 100006457 |
| 10309261 | 10039175 | 1.74 | 58.9 | null | 2020-07-23 | 2020-07-24 | POMALIDOMIDE | 01 | null | TRIAL | 101416033 |
| 10309283 | 10039177 | 1.69 | 58 | Adjuvant (A) | 2016-06-08 | 2016-06-28 | Pazopanib | 02 | N | PAZOPANIB | 101441104 |
| 10309289 | 10039179 | 1.76 | 45 | Adjuvant (A) | 2019-04-04 | 2019-04-04 | CTD Attenuated (Thalidomide 50mg) | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101622398 |
| 10309310 | 10039180 | 1.57 | 75.1 | Curative (C) | 2017-04-22 | 2017-04-23 | DARATUMUMAB | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100501165 |
| 10309416 | 10039181 | 1.55 | 64.3 | Disease modification (D) | 2019-10-17 | 2019-11-11 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100779083 |
| 10309466 | 10039182 | 1.69 | 69 | Adjuvant (A) | 2019-11-24 | 2019-12-05 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100014086 |
| 10309479 | 10039183 | null | null | Palliative (P) | 2017-11-05 | 2017-11-06 | CHOP R - 21 days | 02 | N | CHOP R | 101805859 |
| 10309527 | 10039184 | 1.79 | 88.8 | null | 2016-03-08 | 2016-03-14 | FEC 60 or 75 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100699982 |
| 10309555 | 10039185 | 1.83 | null | 03 | 2018-07-22 | 2018-07-23 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100224821 |
| 10309651 | 10039188 | 1.55 | 99.1 | Palliative (P) | 2019-11-03 | 2019-11-07 | MUK 5 TRIAL | 02 | N | DABRAFENIB + TRAMETINIB | 100734841 |
| 10309681 | 10039189 | 1.62 | 60.3 | Curative (C) | 2018-07-23 | 2018-07-30 | Avelumab | 02 | null | AVELUMAB | 101190369 |
| 10309830 | 10039191 | 1.62 | 0.1 | Adjuvant (A) | 2019-05-11 | 2019-06-24 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101684185 |
| 10309834 | 10039192 | null | null | 03 | 2019-01-25 | 2019-02-22 | R GCVP | null | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100791650 |
| 10309903 | 10039193 | 1.65 | 64.7 | Palliative (P) | 2016-10-16 | 2016-11-02 | POMALIDOMIDE | 02 | N | VENETOCLAX | 100126431 |
| 10309911 | 10039194 | 1.79 | 61 | Adjuvant (A) | 2019-08-29 | 2019-08-29 | Palbociclib | 02 | N | PALBOCICLIB | 101770073 |
| 10309942 | 10039195 | 1.72 | 63 | Palliative (P) | 2018-07-15 | 2018-07-15 | BORTEZOMIB + THALIDOMIDE | 02 | N | BORTEZOMIB + THALIDOMIDE | 100068733 |
| 10309976 | 10039196 | 1.59 | 90.5 | Palliative (P) | 2018-06-12 | 2018-06-12 | Trial Unspecified | 02 | N | CVP R | 100429191 |
| 10309992 | 10039197 | 1.8 | 89.3 | null | null | 2018-05-25 | CTD (Thalidomide 100mg) | 02 | null | DARATUMUMAB | 100136564 |
| 10310022 | 10039198 | 1.72 | null | null | 2018-09-15 | 2018-09-29 | Palbociclib | 02 | null | PALBOCICLIB | 101765366 |
| 10310326 | 10039202 | 1.72 | 71 | Palliative (P) | 2019-07-03 | 2019-07-03 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101523213 |
| 10310346 | 10039203 | 0 | 0 | Adjuvant (A) | 2018-08-13 | 2018-08-14 | Cyclophosphamide + Dex + Rituximab | 02 | N | CISPLATIN + VINORELBINE | 101101721 |